Pub. Date : 2021 Jul
PMID : 33849997
7 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Metformin has beneficial effects in humans in tissues with high levels of mGPD such as pancreatic beta cells where mGPD is much higher than in liver. | Metformin | atypical chemokine receptor 1 (Duffy blood group) | Mus musculus |
| 2 | Metformin has beneficial effects in humans in tissues with high levels of mGPD such as pancreatic beta cells where mGPD is much higher than in liver. | Metformin | atypical chemokine receptor 1 (Duffy blood group) | Mus musculus |
| 3 | For these and other reasons we used four different enzyme assays to reassess whether metformin inhibited mGPD. | Metformin | atypical chemokine receptor 1 (Duffy blood group) | Mus musculus |
| 4 | If metformin actually inhibited mGPD, adverse effects in tissues where the level of mGPD is much higher than in liver could prevent metformin"s use as a diabetes medicine. | Metformin | atypical chemokine receptor 1 (Duffy blood group) | Mus musculus |
| 5 | If metformin actually inhibited mGPD, adverse effects in tissues where the level of mGPD is much higher than in liver could prevent metformin"s use as a diabetes medicine. | Metformin | atypical chemokine receptor 1 (Duffy blood group) | Mus musculus |
| 6 | If metformin actually inhibited mGPD, adverse effects in tissues where the level of mGPD is much higher than in liver could prevent metformin"s use as a diabetes medicine. | Metformin | atypical chemokine receptor 1 (Duffy blood group) | Mus musculus |
| 7 | If metformin actually inhibited mGPD, adverse effects in tissues where the level of mGPD is much higher than in liver could prevent metformin"s use as a diabetes medicine. | Metformin | atypical chemokine receptor 1 (Duffy blood group) | Mus musculus |